ACMSD: A Novel Target for Modulating NAD⁺ Homeostasis

Area of Science:

• Biochemistry
• Metabolic Regulation
• Molecular Biology

Background:

• Nicotinamide adenine dinucleotide (NAD⁺) is essential for numerous biological processes.
• Dysregulation of NAD⁺ metabolism is implicated in various human diseases.
• Understanding NAD⁺ biosynthesis pathways is crucial for therapeutic interventions.

Purpose of the Study:

• To investigate the role of alpha-amino-beta-carboxy-muconate-semialdehyde decarboxylase (ACMSD) in NAD⁺ metabolism.
• To determine the consequences of ACMSD overexpression on NAD⁺ levels and requirements.
• To elucidate the implications of ACMSD activity in niacin/NAD⁺ deficiency-related disorders.

Main Methods:

• Gene expression analysis to study ACMSD levels.
• Metabolic flux analysis to track NAD⁺ biosynthesis.
• In vivo studies using genetically modified mice to assess niacin dependency.

Main Results:

• ACMSD was identified as a key regulator of NAD⁺ metabolism.
• Overexpression of human ACMSD in mice resulted in a significant dependency on niacin for NAD⁺ production.
• This overexpression altered the metabolic pathways involved in NAD⁺ biosynthesis.

Conclusions:

• ACMSD plays a critical role in controlling the rate of NAD⁺ biosynthesis.
• ACMSD activity influences the requirement for niacin, a precursor for NAD⁺.
• These findings offer insights into diseases linked to niacin/NAD⁺ deficiency and suggest ACMSD as a potential therapeutic target.